Skip to main content
Top
Published in: BMC Medicine 1/2014

Open Access 01-12-2014 | Review

Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions

Authors: Wendy Stevens, Natasha Gous, Nathan Ford, Lesley E Scott

Published in: BMC Medicine | Issue 1/2014

Login to get access

Abstract

Improved access to anti-retroviral therapy increases the need for affordable monitoring using assays such as CD4 and/or viral load in resource-limited settings. Barriers to accessing treatment, high rates of loss to initiation and poor retention in care are prompting the need to find alternatives to conventional centralized laboratory testing in certain countries. Strong advocacy has led to a rapidly expanding repertoire of point-of-care tests for HIV. point-of-care testing is not without its challenges: poor regulatory control, lack of guidelines, absence of quality monitoring and lack of industry standards for connectivity, to name a few. The management of HIV increasingly requires a multidisciplinary testing approach involving hematology, chemistry, and tests associated with the management of non-communicable diseases, thus added expertise is needed. This is further complicated by additional human resource requirements and the need for continuous training, a sustainable supply chain, and reimbursement strategies. It is clear that to ensure appropriate national implementation either in a tiered laboratory model or a total decentralized model, clear country-specific assessments need to be conducted.
Literature
6.
go back to reference De Cock KM, El-Sadr WM: Perspective: When to start ART in Africa—an urgent research priority. N Engl J Med. 2013, 368: 886-889. 10.1056/NEJMp1300458.CrossRefPubMedPubMedCentral De Cock KM, El-Sadr WM: Perspective: When to start ART in Africa—an urgent research priority. N Engl J Med. 2013, 368: 886-889. 10.1056/NEJMp1300458.CrossRefPubMedPubMedCentral
7.
go back to reference Nkengasong JN: A shifting paradigm in strengthening laboratory health systems for global health: acting now, acting collectively, but acting differently. Am J Clin Pathol. 2010, 134: 359-360. 10.1309/AJCPY5ASUEJYQ5RK.CrossRefPubMed Nkengasong JN: A shifting paradigm in strengthening laboratory health systems for global health: acting now, acting collectively, but acting differently. Am J Clin Pathol. 2010, 134: 359-360. 10.1309/AJCPY5ASUEJYQ5RK.CrossRefPubMed
8.
go back to reference Clouse K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, Gay C, Sanne I, Fox MP: Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2013, 62: e39-e46. 10.1097/QAI.0b013e318273ac48.CrossRefPubMedPubMedCentral Clouse K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, Gay C, Sanne I, Fox MP: Patient retention from HIV diagnosis through one year on antiretroviral therapy at a primary health care clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2013, 62: e39-e46. 10.1097/QAI.0b013e318273ac48.CrossRefPubMedPubMedCentral
9.
go back to reference Govender N, Chetty V, Roy M, Chiller TM, Oladoyinbo S, Maotoe T, Stevens WS, Pinini Z, Spencer D, Venter F, Jassat W, Cameron D, Meintjes G, Mbengashe T, Pillay Y: Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J. 2012, 102: 914-917. 10.7196/samj.6228.CrossRefPubMed Govender N, Chetty V, Roy M, Chiller TM, Oladoyinbo S, Maotoe T, Stevens WS, Pinini Z, Spencer D, Venter F, Jassat W, Cameron D, Meintjes G, Mbengashe T, Pillay Y: Phased implementation of screening for cryptococcal disease in South Africa. S Afr Med J. 2012, 102: 914-917. 10.7196/samj.6228.CrossRefPubMed
10.
go back to reference Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia de la Vega F, Perrin L, Rodriguez W: HIV viral load monitoring in resource-limited regions: optional or necessary?. Clin Infect Dis. 2007, 44: 128-134. 10.1086/510073.CrossRefPubMed Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia de la Vega F, Perrin L, Rodriguez W: HIV viral load monitoring in resource-limited regions: optional or necessary?. Clin Infect Dis. 2007, 44: 128-134. 10.1086/510073.CrossRefPubMed
11.
go back to reference Rutherford GW, Anglemyer A, Easterbrook PJ, Horvath T, Vitoria M, Penazzato M, Doherty MC: Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. AIDS. 2014, 2: S161-S169. 10.1097/QAD.0000000000000236.CrossRef Rutherford GW, Anglemyer A, Easterbrook PJ, Horvath T, Vitoria M, Penazzato M, Doherty MC: Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure. AIDS. 2014, 2: S161-S169. 10.1097/QAD.0000000000000236.CrossRef
14.
go back to reference Gale HB, Gitterman SR, Hoffman HJ, Gordin FM, Benator DA, Labriola AM, Kan VL: Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts > =300 cells/uL and HIV-1 suppression?. Clin Infect Dis. 2013, 56: 1340-1343. 10.1093/cid/cit004.CrossRefPubMedPubMedCentral Gale HB, Gitterman SR, Hoffman HJ, Gordin FM, Benator DA, Labriola AM, Kan VL: Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts > =300 cells/uL and HIV-1 suppression?. Clin Infect Dis. 2013, 56: 1340-1343. 10.1093/cid/cit004.CrossRefPubMedPubMedCentral
15.
go back to reference Mosen DM, Horberg M, Roblin D, Gullion CM, Meenan R, Leyden W, Hu W: Effect of once-daily FDC treatment era on initiation of cART. HIV AIDS (Auckl). 2010, 2: 19-26. Mosen DM, Horberg M, Roblin D, Gullion CM, Meenan R, Leyden W, Hu W: Effect of once-daily FDC treatment era on initiation of cART. HIV AIDS (Auckl). 2010, 2: 19-26.
18.
go back to reference Kost GJ: Point-of-care testing in intensive care, and planning and implementing point-of-care test systems. Principles and Practice of Intensive Care Monitoring. Edited by: Tobin MA. 1998, McGraw Hill, New York, NY, 1267-1328. Kost GJ: Point-of-care testing in intensive care, and planning and implementing point-of-care test systems. Principles and Practice of Intensive Care Monitoring. Edited by: Tobin MA. 1998, McGraw Hill, New York, NY, 1267-1328.
19.
go back to reference Zucker ML: Point of care testing guideline published by CLSI. Lab Medicine. 2010, 41: 499-500. 10.1309/LM22RU1RCUXZPRXN.CrossRef Zucker ML: Point of care testing guideline published by CLSI. Lab Medicine. 2010, 41: 499-500. 10.1309/LM22RU1RCUXZPRXN.CrossRef
20.
go back to reference Kilgore ML, Steindel SJ, Smith JA: Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing. J Healthc Manag. 1999, 44: 207-215.PubMed Kilgore ML, Steindel SJ, Smith JA: Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing. J Healthc Manag. 1999, 44: 207-215.PubMed
21.
go back to reference Kost GJ, Ehrmeyer SS, Chernow B, Winkelman JW, Zaloga GP, Dellinger RP, Shirey T: The laboratory-clinical interface: point-of-care testing. Chest. 1999, 115: 1140-1154. 10.1378/chest.115.4.1140.CrossRefPubMed Kost GJ, Ehrmeyer SS, Chernow B, Winkelman JW, Zaloga GP, Dellinger RP, Shirey T: The laboratory-clinical interface: point-of-care testing. Chest. 1999, 115: 1140-1154. 10.1378/chest.115.4.1140.CrossRefPubMed
22.
go back to reference Plebani M: Does POCT reduce the risk of error in laboratory testing?. Clin Chim Acta. 2009, 404: 59-64. 10.1016/j.cca.2009.03.014.CrossRefPubMed Plebani M: Does POCT reduce the risk of error in laboratory testing?. Clin Chim Acta. 2009, 404: 59-64. 10.1016/j.cca.2009.03.014.CrossRefPubMed
23.
go back to reference Warsinke A: Point-of-care testing of proteins. Anal Bioanal Chem. 2009, 393: 1393-1405. 10.1007/s00216-008-2572-0.CrossRefPubMed Warsinke A: Point-of-care testing of proteins. Anal Bioanal Chem. 2009, 393: 1393-1405. 10.1007/s00216-008-2572-0.CrossRefPubMed
24.
go back to reference Hammett-Stabler CA, Nichols JH: Point-of-care testing, a critical component of laboratory medicine. Clin Biochem. 2009, 42: 135-10.1016/j.clinbiochem.2008.09.097.CrossRefPubMed Hammett-Stabler CA, Nichols JH: Point-of-care testing, a critical component of laboratory medicine. Clin Biochem. 2009, 42: 135-10.1016/j.clinbiochem.2008.09.097.CrossRefPubMed
25.
go back to reference Lewandrowski K: Point-of-care testing: an overview and a look to the future (circa 2009, United States). Clin Lab Med. 2009, 29: 421-432. 10.1016/j.cll.2009.06.015.CrossRefPubMed Lewandrowski K: Point-of-care testing: an overview and a look to the future (circa 2009, United States). Clin Lab Med. 2009, 29: 421-432. 10.1016/j.cll.2009.06.015.CrossRefPubMed
26.
go back to reference Girardin CM, Huot C, Gonthier M, Delvin E: Continuous glucose monitoring: a review of biochemical perspectives and clinical use in type 1 diabetes. Clin Biochem. 2009, 42: 136-142. 10.1016/j.clinbiochem.2008.09.112.CrossRefPubMed Girardin CM, Huot C, Gonthier M, Delvin E: Continuous glucose monitoring: a review of biochemical perspectives and clinical use in type 1 diabetes. Clin Biochem. 2009, 42: 136-142. 10.1016/j.clinbiochem.2008.09.112.CrossRefPubMed
27.
go back to reference Sorger PK: Microfluidics closes in on point-of-care assays. Nat Biotechnol. 2008, 26: 1345-1346. 10.1038/nbt1208-1345.CrossRefPubMed Sorger PK: Microfluidics closes in on point-of-care assays. Nat Biotechnol. 2008, 26: 1345-1346. 10.1038/nbt1208-1345.CrossRefPubMed
28.
go back to reference Kricka LJ: Microchips, microarrays, biochips and nanochips: personal laboratories for the 21st century. Clin Chim Acta. 2001, 307: 219-223. 10.1016/S0009-8981(01)00451-X.CrossRefPubMed Kricka LJ: Microchips, microarrays, biochips and nanochips: personal laboratories for the 21st century. Clin Chim Acta. 2001, 307: 219-223. 10.1016/S0009-8981(01)00451-X.CrossRefPubMed
29.
go back to reference Alharbi KK, Al-Sheikh YA: Role and implications of nanodiagnostics in the changing trends of clinical diagnosis. Saudi J Biol Sci. 2014, 21: 109-117. 10.1016/j.sjbs.2013.11.001.CrossRefPubMed Alharbi KK, Al-Sheikh YA: Role and implications of nanodiagnostics in the changing trends of clinical diagnosis. Saudi J Biol Sci. 2014, 21: 109-117. 10.1016/j.sjbs.2013.11.001.CrossRefPubMed
30.
go back to reference Syed MA: Advances in nanodiagnostic techniques for microbial agents. Biosens Bioelectron. 2014, 51: 391-400. 10.1016/j.bios.2013.08.010.CrossRefPubMed Syed MA: Advances in nanodiagnostic techniques for microbial agents. Biosens Bioelectron. 2014, 51: 391-400. 10.1016/j.bios.2013.08.010.CrossRefPubMed
31.
go back to reference Jani IV, Peter T: How point-of-care testing could drive innovation in global health. New Engl J Med. 2013, 368: 2319-2324. 10.1056/NEJMsb1214197.CrossRefPubMed Jani IV, Peter T: How point-of-care testing could drive innovation in global health. New Engl J Med. 2013, 368: 2319-2324. 10.1056/NEJMsb1214197.CrossRefPubMed
35.
go back to reference Fox MP, Shearer K, Maskew M, Macleod W, Majuba P, Macphail P, Sanne I: Treatment outcomes after 7 years of public-sector HIV treatment. AIDS. 2012, 26: 1823-1828. 10.1097/QAD.0b013e328357058a.CrossRefPubMedPubMedCentral Fox MP, Shearer K, Maskew M, Macleod W, Majuba P, Macphail P, Sanne I: Treatment outcomes after 7 years of public-sector HIV treatment. AIDS. 2012, 26: 1823-1828. 10.1097/QAD.0b013e328357058a.CrossRefPubMedPubMedCentral
37.
go back to reference Peeling RW, McNerney R: Emerging technologies in point-of-care molecular diagnostics for resource-limited settings. Expert Rev Mol Diagn. 2014, 14: 525-534. 10.1586/14737159.2014.915748.CrossRefPubMed Peeling RW, McNerney R: Emerging technologies in point-of-care molecular diagnostics for resource-limited settings. Expert Rev Mol Diagn. 2014, 14: 525-534. 10.1586/14737159.2014.915748.CrossRefPubMed
40.
go back to reference Jani IV, Meggi B, Mabunda N, Vubil A, Sitoe NE, Tobaiwa O, Quevedo JI, Lehe JD, Loquiha O, Vojnov L, Peter TF: Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test. J Acquir Immune Defic Syndr. 2014, 16: e1-e4. 10.1097/QAI.0000000000000250.CrossRef Jani IV, Meggi B, Mabunda N, Vubil A, Sitoe NE, Tobaiwa O, Quevedo JI, Lehe JD, Loquiha O, Vojnov L, Peter TF: Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test. J Acquir Immune Defic Syndr. 2014, 16: e1-e4. 10.1097/QAI.0000000000000250.CrossRef
41.
go back to reference Lee H: Point of care HIV molecular tests: Bridging the gap between laboratory and patient. Presentation in 1st International Conference of the African Society for Laboratory Medicine: 2012 December 1-7; Cape Town, South Africa. 2013, ASLM, Cape Town Lee H: Point of care HIV molecular tests: Bridging the gap between laboratory and patient. Presentation in 1st International Conference of the African Society for Laboratory Medicine: 2012 December 1-7; Cape Town, South Africa. 2013, ASLM, Cape Town
42.
go back to reference Logan C, Givens M, Ives JT, Delaney M, Lochhead MJ, Schooley RT, Benson CA: Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. J Immunol Methods. 2013, 387: 107-113. 10.1016/j.jim.2012.10.002.CrossRefPubMed Logan C, Givens M, Ives JT, Delaney M, Lochhead MJ, Schooley RT, Benson CA: Performance evaluation of the MBio Diagnostics point-of-care CD4 counter. J Immunol Methods. 2013, 387: 107-113. 10.1016/j.jim.2012.10.002.CrossRefPubMed
43.
go back to reference Bornheimer S, Bui N, Le D, Wai H, Tran A, Goldberg E, Bouic P, Huang W, Sugarman J, Crowe M, Kumar V, Shook J, Tomas C, Yu J, Clark A, Broszeit E, Chen R, Bush-Donovan C: Development of the BD FACSPresto instrument, a new point-of-care system for CD4+ counting. Poster presentation TUPE265 in 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention: 2013 June 30 - July 3, Kuala Lumpur. 2013, International AIDS Society, Kuala Lumpur Bornheimer S, Bui N, Le D, Wai H, Tran A, Goldberg E, Bouic P, Huang W, Sugarman J, Crowe M, Kumar V, Shook J, Tomas C, Yu J, Clark A, Broszeit E, Chen R, Bush-Donovan C: Development of the BD FACSPresto instrument, a new point-of-care system for CD4+ counting. Poster presentation TUPE265 in 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention: 2013 June 30 - July 3, Kuala Lumpur. 2013, International AIDS Society, Kuala Lumpur
45.
go back to reference Gandelman OA, Church VL, Moore CA, Kiddle G, Carne CA, Parmar S, Jalal H, Tisi LC, Murray JA: Novel bioluminescent quantitative detection of nucleic acid amplification in real-time. PLoS One. 2010, 5: e14155-10.1371/journal.pone.0014155.CrossRefPubMedPubMedCentral Gandelman OA, Church VL, Moore CA, Kiddle G, Carne CA, Parmar S, Jalal H, Tisi LC, Murray JA: Novel bioluminescent quantitative detection of nucleic acid amplification in real-time. PLoS One. 2010, 5: e14155-10.1371/journal.pone.0014155.CrossRefPubMedPubMedCentral
46.
go back to reference Laurence C, Gialamas A, Yelland L, Bubner T, Ryan P, Willson K, Glastonbury B, Gill J, Shephard M, Beilby J: A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics. Trials. 2008, 9: 50-10.1186/1745-6215-9-50.CrossRefPubMedPubMedCentral Laurence C, Gialamas A, Yelland L, Bubner T, Ryan P, Willson K, Glastonbury B, Gill J, Shephard M, Beilby J: A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting - rationale, design and baseline characteristics. Trials. 2008, 9: 50-10.1186/1745-6215-9-50.CrossRefPubMedPubMedCentral
47.
go back to reference Shephard MD, Mazzachi BC, Watkinson L, Shephard AK, Laurence C, Gialamas A, Bubner T: Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices. Rural Remote Health. 2009, 9: 1189.PubMed Shephard MD, Mazzachi BC, Watkinson L, Shephard AK, Laurence C, Gialamas A, Bubner T: Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices. Rural Remote Health. 2009, 9: 1189.PubMed
48.
go back to reference Shephard MD: Influence of geography on the performance of quality control testing in the Australian Government's point of care testing in general practice trial. Clin Biochem. 2009, 42: 1325-1327. 10.1016/j.clinbiochem.2009.05.008.CrossRefPubMed Shephard MD: Influence of geography on the performance of quality control testing in the Australian Government's point of care testing in general practice trial. Clin Biochem. 2009, 42: 1325-1327. 10.1016/j.clinbiochem.2009.05.008.CrossRefPubMed
49.
go back to reference South African National Department of Health, National Health Laboratory Service: Point-of-care testing: Position paper Forum Report to support National Strategic Plan for POCT for the management of HIV and TB in South Africa: An overview of the Point-Of Care Forum hosted by the National Department of Health. 2013. In preparation. South African National Department of Health, National Health Laboratory Service: Point-of-care testing: Position paper Forum Report to support National Strategic Plan for POCT for the management of HIV and TB in South Africa: An overview of the Point-Of Care Forum hosted by the National Department of Health. 2013. In preparation.
50.
go back to reference Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, Lehe JD, Peter TF: Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011, 378: 1572-1579. 10.1016/S0140-6736(11)61052-0.CrossRefPubMed Jani IV, Sitoe NE, Alfai ER, Chongo PL, Quevedo JI, Rocha BM, Lehe JD, Peter TF: Effect of point-of-care CD4 cell count tests on retention of patients and rates of antiretroviral therapy initiation in primary health clinics: an observational cohort study. Lancet. 2011, 378: 1572-1579. 10.1016/S0140-6736(11)61052-0.CrossRefPubMed
52.
go back to reference Benzaken AS, Bazzo ML, Galban E, Pinto IC, Nogueira CL, Golfetto L, Benzaken NS, Sollis KA, Mabey D, Peeling RW: External quality assurance with dried tube specimens (DTS) for point-of-care syphilis and HIV tests: experience in an indigenous populations screening programme in the Brazilian Amazon. Sex Transm Infect. 2014, 90: 14-18.CrossRefPubMed Benzaken AS, Bazzo ML, Galban E, Pinto IC, Nogueira CL, Golfetto L, Benzaken NS, Sollis KA, Mabey D, Peeling RW: External quality assurance with dried tube specimens (DTS) for point-of-care syphilis and HIV tests: experience in an indigenous populations screening programme in the Brazilian Amazon. Sex Transm Infect. 2014, 90: 14-18.CrossRefPubMed
53.
go back to reference Gous N, Cunningham B, Kana B, Stevens W, Scott LE: Performance monitoring of mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa. J Clin Microbiol. 2013, 51: 4018-4021. 10.1128/JCM.01715-13.CrossRefPubMedPubMedCentral Gous N, Cunningham B, Kana B, Stevens W, Scott LE: Performance monitoring of mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa. J Clin Microbiol. 2013, 51: 4018-4021. 10.1128/JCM.01715-13.CrossRefPubMedPubMedCentral
54.
go back to reference Scott LE, Gous N, Cunningham BE, Kana BD, Perovic O, Erasmus L, Coetzee GJ, Koornhof H, Stevens W: Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J Clin Microbiol. 2011, 49: 4356-4360. 10.1128/JCM.05167-11.CrossRefPubMedPubMedCentral Scott LE, Gous N, Cunningham BE, Kana BD, Perovic O, Erasmus L, Coetzee GJ, Koornhof H, Stevens W: Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J Clin Microbiol. 2011, 49: 4356-4360. 10.1128/JCM.05167-11.CrossRefPubMedPubMedCentral
56.
go back to reference Kessler HH, Jungkind D, Stelzl E, Direnzo S, Vellimedu SK, Pierer K, Santner B, Marth E: Evaluation of AMPLILINK software for the COBAS AMPLICOR system. J Clin Microbiol. 1999, 37: 436-437.PubMedPubMedCentral Kessler HH, Jungkind D, Stelzl E, Direnzo S, Vellimedu SK, Pierer K, Santner B, Marth E: Evaluation of AMPLILINK software for the COBAS AMPLICOR system. J Clin Microbiol. 1999, 37: 436-437.PubMedPubMedCentral
57.
go back to reference St John A, Merkle H: A connectivity standard for point-of-care testing. Med Device Technol. 2001, 12: 23-26.PubMed St John A, Merkle H: A connectivity standard for point-of-care testing. Med Device Technol. 2001, 12: 23-26.PubMed
59.
go back to reference Faal M, Naidoo N, Glencross DK, Venter WD, Osih R: Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr. 2011, 58: e54-e59. 10.1097/QAI.0b013e3182303921.CrossRefPubMed Faal M, Naidoo N, Glencross DK, Venter WD, Osih R: Providing immediate CD4 count results at HIV testing improves ART initiation. J Acquir Immune Defic Syndr. 2011, 58: e54-e59. 10.1097/QAI.0b013e3182303921.CrossRefPubMed
60.
go back to reference Manyazewal T, Paterniti AD, Redfield RR, Marinucci F: Role of secondary level laboratories in strengthening quality at primary health care facilities’ laboratories: an innovative approach to ensure accurate HIV, tuberculosis and malaria tests is resource-limited settings. Diagn Microbiol Infect Dis. 2013, 75: 55-59. 10.1016/j.diagmicrobio.2012.09.020.CrossRefPubMed Manyazewal T, Paterniti AD, Redfield RR, Marinucci F: Role of secondary level laboratories in strengthening quality at primary health care facilities’ laboratories: an innovative approach to ensure accurate HIV, tuberculosis and malaria tests is resource-limited settings. Diagn Microbiol Infect Dis. 2013, 75: 55-59. 10.1016/j.diagmicrobio.2012.09.020.CrossRefPubMed
Metadata
Title
Feasibility of HIV point-of-care tests for resource-limited settings: challenges and solutions
Authors
Wendy Stevens
Natasha Gous
Nathan Ford
Lesley E Scott
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2014
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-014-0173-7

Other articles of this Issue 1/2014

BMC Medicine 1/2014 Go to the issue